Cancer Adoptive Cellular Therapy Network (Can-ACT) Coordinating Center (U24 Clinical Trial Not Allowed)

Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) intends to support a coordinating center to manage the Cancer Adoptive Cell Therapy (Can-ACT) Network a network of UG3/UH3 awardees that will conduct adoptive cell therapy research and clinical trials for patients with solid tumors (see companion UG3/UH3 FOAs - RFA-CA-22-028 and RFA-CA-22-029). The U24 Coordinating Center will organize and administer a Steering Committee for the Can-ACT Network to ensure that the goals of the network are achieved. The Coordinating Center will oversee the management of network activities to facilitate multi-site clinical trial coordination and data collection, harmonization, quality, and sharing.